Cel Sci Stock Price

-0.17 (-2.92%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 1,193,725
Bid Price
Ask Price
News -
Day High 6.13


52 Week Range


Day Low 5.63
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cel Sci Corporation New CVM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.17 -2.92% 5.65 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.80 5.63 6.13 5.64 5.82
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,344 1,193,725 $ 5.88 $ 7,015,712 - 5.63 - 40.91
Last Trade Time Type Quantity Stock Price Currency
20:00:00 93,800 $ 5.64 USD


Draw Mode:

Cel Sci Corporation New Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 244.33M 43.24M 36.99M $ - $ - -0.93 -6.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 236.33k 6.70%

more financials information »

Cel Sci News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CVM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week6.006.665.636.13981,099-0.35-5.83%
1 Month8.258.375.636.71670,976-2.60-31.52%
3 Months11.6812.825.638.94859,093-6.03-51.63%
6 Months7.6512.905.639.60769,869-2.00-26.14%
1 Year14.8140.915.6314.391,189,291-9.16-61.85%
3 Years2.7540.912.366812.12872,9632.90105.45%
5 Years2.72540.910.81657.92939,8882.93107.34%

Cel Sci Description

CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.

Your Recent History
Cel Sci
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.